|
CLTB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.73700000000765E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.98019999999977E-05 |
| Normal-vs-Stage2 |
2.52040000003895E-06 |
| Normal-vs-Stage3 |
6.630400E-01 |
| Normal-vs-Stage4 |
1.609580E-01 |
| Stage1-vs-Stage2 |
7.030500E-02 |
| Stage1-vs-Stage3 |
3.772400E-02 |
| Stage1-vs-Stage4 |
7.704600E-01 |
| Stage2-vs-Stage3 |
6.240800E-03 |
| Stage2-vs-Stage4 |
2.754200E-01 |
| Stage3-vs-Stage4 |
2.645400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.32290000004676E-06 |
| Normal-vs-AfricanAmerican |
1.258110E-02 |
| Normal-vs-Asian |
6.514000E-01 |
| Caucasian-vs-AfricanAmerican |
1.608200E-01 |
| Caucasian-vs-Asian |
2.485600E-01 |
| AfricanAmerican-vs-Asian |
3.526800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77840000004093E-06 |
| Normal-vs-Female |
2.587400E-01 |
| Male-vs-Female |
1.299630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.083700E-03 |
| Normal-vs-Extreme_Weight |
1.682210E-02 |
| Normal-vs-Obese |
9.976000E-04 |
| Normal-vs-Extreme_Obese |
2.180000E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.437600E-01 |
| Normal_Weight-vs-Obese |
7.007200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.284200E-01 |
| Extreme_Weight-vs-Obese |
4.612200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.481600E-01 |
| Obese-vs-Extreme_Obese |
4.613800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.415000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.956900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.395299999991E-05 |
| Normal-vs-Age(81-100Yrs) |
9.716400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.843000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.903000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.005800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.408800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.497000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.998000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.31269999992645E-07 |
| Normal-VS-Type2 PRCC |
5.366000E-02 |
| Normal-VS-KIRP CIMP |
1.596010E-01 |
| Normal-VS-Unclassified PRCC |
7.810300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.864500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.156000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.022400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.253400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.915000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.157800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.019610E-01 |
| Normal-vs-N1 |
1.547390E-01 |
| Normal-vs-N2 |
6.807600E-01 |
| N0-vs-N1 |
9.576600E-01 |
| N0-vs-N2 |
7.380800E-01 |
| N1-vs-N2 |
6.950800E-01 |
|
|
